If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 136.10
Bid: 135.70
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 0.30 (0.221%)
Open: 137.40
High: 137.60
Low: 134.30
Prev. Close: 136.10
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of shares and total voting rights

2 Nov 2023 08:00

RNS Number : 1147S
Aston Martin Lagonda Glob.Hldgs PLC
02 November 2023

2 November 2023

Aston Martin Lagonda Global Holdings plc

("Aston Martin" or the "Company")

Progress to completion of Lucid Transaction and Admission of Consideration SharesTotal Voting Rights

Further to its announcement on 19 September 2023 confirming the receipt of shareholder approvals in connection with the strategic supply arrangement with Lucid Group, Inc. ("Lucid") (the "Transaction"), Aston Martin is today pleased to announce that clearance from all applicable regulatory and antitrust authorities has been obtained and the Transaction can proceed to completion.

Accordingly, the Company announces that, subject and pursuant to the previously disclosed terms of the Transaction:

· 28,352,273 new ordinary shares of £0.10 each in its share capital (the "Consideration Shares") will be allotted and issued to Lucid's subsidiary, Atieva, Inc.

· Integration and supply agreements between Aston Martin and Lucid governing Aston Martin's access to certain of Lucid's industry-leading technologies, including electric powertrains and battery systems, will become effective from Admission of the Consideration Shares

Applications have been made to the Financial Conduct Authority (the "FCA") and the London Stock Exchange plc (the "LSE") respectively for the admission of the Consideration Shares to listing on the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the LSE (together, "Admission"). It is expected that Admission will become effective at 8.00 a.m. on 6 November 2023.

In accordance with the FCA's Disclosure Guidance and Transparency Rules, the Company also notifies that, following Admission becoming effective, the total issued share capital of the Company will be 823,663,785 ordinary shares of £0.10 each with one voting right per share. There are no ordinary shares held in treasury.

Therefore, following Admission becoming effective, the total number of voting rights in the Company will be 823,663,785 and this figure should be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Enquiries

Investors and Analysts

Robert Berg Director of Investor Relations +44 (0) 7833 080458

robert.berg@astonmartin.com

Ella South Investor Relations Analyst +44 (0) 7776 545420

ella.south@astonmartin.com

Media

Kevin Watters Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Paul Garbett Head of Corporate & Brand Communications +44 (0)7501 380799

paul.garbett@astonmartin.com

Teneo

Harry Cameron +44 (0)20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ALSFFFIILALLIIV
Date   Source Headline
1st Oct 202112:08 pmRNSTotal Voting Rights
31st Aug 202110:37 amRNSTotal Voting Rights
12th Aug 202110:58 amRNSDirector/PDMR Shareholding
3rd Aug 20212:35 pmRNSDirector/PDMR Shareholding
29th Jul 202110:00 amRNSTotal Voting Rights
28th Jul 20217:00 amRNSInterim results for the six months to 30 June 2021
26th Jul 20217:00 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSAdditional Listing
15th Jul 20217:00 amRNSAdditional Listing
8th Jul 20217:00 amRNSDirectorate Change
29th Jun 20212:00 pmRNSDirector/PDMR Shareholding
29th Jun 202110:45 amRNSTotal Voting Rights
22nd Jun 20217:00 amRNSCommencement of legal proceedings
16th Jun 20212:00 pmRNSDirector/PDMR Shareholding
15th Jun 202111:06 amRNSDirector/PDMR Shareholding
28th May 20219:30 amRNSTotal Voting Rights
25th May 20211:00 pmRNSResult of AGM
10th May 202111:00 amRNSDirector/PDMR Shareholding
6th May 20217:00 amRNS1st Quarter Results
29th Apr 20219:30 amRNSTotal Voting Rights
21st Apr 20219:30 amRNSNotice of AGM
19th Apr 20217:15 amRNSDeath of Non-Executive Director
6th Apr 20211:45 pmRNSDirector Declaration - Correction
6th Apr 20211:00 pmRNSDirector Declaration
30th Mar 202110:30 amRNSTotal Voting Rights
11th Mar 202111:34 amRNSAnnual Financial Report
3rd Mar 20212:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20219:30 amRNSDirector/PDMR Shareholding
26th Feb 20219:30 amRNSTotal Voting Rights
25th Feb 20216:04 pmRNSIssue of Debt
25th Feb 202110:30 amRNSIssue of Debt
25th Feb 20217:00 amRNSFinal Results
19th Feb 20211:32 pmRNSDirectorate Change
28th Jan 202112:25 pmRNSTotal Voting Rights
28th Jan 20219:00 amRNSDirectorate Change
30th Dec 202010:00 amRNSTotal Voting Rights
29th Dec 20209:00 amRNSHolding(s) in Company
15th Dec 20209:30 amRNSDirector/PDMR Shareholding
10th Dec 202010:00 amRNSHolding(s) in Company
9th Dec 20204:43 pmRNSDirector/PDMR Shareholding - Replacement
9th Dec 20201:30 pmRNSHolding(s) in Company
9th Dec 20201:30 pmRNSHolding(s) in Company
9th Dec 20201:30 pmRNSDirector/PDMR Shareholding
9th Dec 20209:17 amRNSHolding(s) in Company
7th Dec 20207:00 amRNSAdmission of Placing and Consideration Shares
4th Dec 20209:51 amRNSResult of the General Meeting
30th Nov 202010:00 amRNSTotal Voting Rights
26th Nov 20209:31 amRNSSatisfaction of Antitrust Conditions
18th Nov 20201:40 pmRNSPublication of a Prospectus
13th Nov 20203:25 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.